Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 611.00
+10.00 (1.66%)
At close: Dec 2, 2024, 1:30 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 119.20 billion as of May 13, 2025. Its market cap has increased by 117.01% in one year.
Market Cap
119.20B
Enterprise Value
109.66B
Revenue
40.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
611.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 119.20B, an increase of 1,397.83%. That is a compound annual growth rate of 211.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 119.20B | 26.32% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 166.19B |
| Bora Pharmaceuticals Co., LTD. | 73.49B |
| Lotus Pharmaceutical | 60.56B |
| Polaris Group | 32.43B |
| Oneness Biotech | 29.46B |
| Pegavision | 27.14B |
| Lumosa Therapeutics | 26.85B |
| Center Laboratories | 26.08B |